Why the space between visits is a blind spot, and what it costs

Chronic medication is managed in appointments that are minutes long and weeks apart. Almost everything that determines the outcome happens in between, where no one is looking.

The blind spot

Between visits, the clinician depends on what the patient remembers. Side effects, adherence, and daily tolerance fade or blur by the next appointment. Decisions get made on a partial story.

What it costs

The cost shows up as avoidable discontinuation, slower adjustments, and visits spent reconstructing the past instead of planning the next step. A patient who quietly struggled for weeks often stops before anyone knew there was a problem.

Closing it

A structured between-visit record gives the clinician the missing context. The visit starts from what actually happened rather than from memory.